Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

Update Il y a 4 ans
Reference: NCT01510028

Woman and Man

Extract

The purpose of this study is to determine the safety of ascending doses of HGT-1110 administered by intrathecal (IT) injection for 38 weeks (20 injections) in children with metachromatic leukodystrophy (MLD).


Inclusion criteria

  • Metachromatic Leukodystrophy (MLD)


Links